Bioprocess Optimization and Digital Bio-manufacturing Global Market Report 2025: Demand for Biologics Fuels Rapid Growth in Advanced Bioprocess Technologies and Analytics
13 janv. 2025 04h29 HE
|
Research and Markets
Dublin, Jan. 13, 2025 (GLOBE NEWSWIRE) -- The "Bioprocess Optimization and Digital Bio-manufacturing: Global Markets" report has been added to ResearchAndMarkets.com's offering. Over the last few...
Cancer Immunotherapy Global Market Overview 2023-2030, Competitive Analysis of Amgen, AstraZeneca,Bayer, BMS, Eli Lilly, F. Hoffmann-La Roche, GSK, Immunocore, J&J, Merck, Novartis, Pfizer
10 janv. 2025 04h06 HE
|
Research and Markets
Dublin, Jan. 10, 2025 (GLOBE NEWSWIRE) -- The "Cancer Immunotherapy - A Global Market Overview" report has been added to ResearchAndMarkets.com's offering.The global market for Cancer Immunotherapy...
Antibodies Contract Manufacturing Market Research 2024 with Global Long-term Forecasts to 2035: Expansion of Emerging Markets, Personalized Medicine, Therapeutic Antibodies Demand Fueling Growth
08 janv. 2025 11h42 HE
|
Research and Markets
Dublin, Jan. 08, 2025 (GLOBE NEWSWIRE) -- The "Antibodies Contract Manufacturing Market by Product, by Source, by End-User, and By Region" report has been added to ResearchAndMarkets.com's...
Cell Harvesting Systems Market to Cross Revenues of $26.6 Billion by 2034 - Evolving Healthcare Landscape Spurs Demand for Regenerative Medicine and Cell-Based Therapies
08 janv. 2025 10h28 HE
|
Research and Markets
Dublin, Jan. 08, 2025 (GLOBE NEWSWIRE) -- The "Cell Harvesting System Market by Type, Application, End User and Region" report has been added to ResearchAndMarkets.com's offering. This...
8MM Respiratory Syncytial Virus Prophylaxis Market Drug Analysis Report: Prophylactic Options to Continue to Diversify Due to Strength of Late-Stage Pipeline - Forecast to 2030
20 déc. 2024 10h05 HE
|
Research and Markets
Dublin, Dec. 20, 2024 (GLOBE NEWSWIRE) -- The "Respiratory Syncytial Virus Prophylaxis: Eight-Market Drug Forecast and Market Analysis - Update" report has been added to ResearchAndMarkets.com's...
Myositis Therapeutics Market Report 2024: Comprehensive Insights about 18+ Companies and 20+ Pipeline Drugs
18 déc. 2024 09h37 HE
|
Research and Markets
Dublin, Dec. 18, 2024 (GLOBE NEWSWIRE) -- The "Myositis - Pipeline Insight, 2024" drug pipelines has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights...
Bio Usawa Names Former Ghana Food and Drug Authority Director Eric Karikari-Boateng as Head of Global Regulatory Strategy
17 déc. 2024 10h15 HE
|
Bio Usawa Inc
Bio Usawa, Inc., a company committed to delivering affordable biotherapies in Africa, named Eric Karikari-Boateng its Head of Global Regulatory Strategy
FcRn Inhibitor Market Size, Target Population, Competitive Landscape & Forecast to 2034 - Immunovant Advances FcRn Inhibitor Pipeline with Promising Results and FDA Green Light for Pivotal Trial
11 déc. 2024 06h25 HE
|
Research and Markets
Dublin, Dec. 11, 2024 (GLOBE NEWSWIRE) -- The "FcRn Inhibitor Market Size, Target Population, Competitive Landscape & Market Forecast - 2034" report has been added to ResearchAndMarkets.com's...
Chronic Pseudomonas Aeruginosa Pulmonary Infections Pipeline Insight 2024 - Pipeline Drug Profiles, Including Clinical and Non-clinical Stage Products
06 déc. 2024 04h13 HE
|
Research and Markets
Dublin, Dec. 06, 2024 (GLOBE NEWSWIRE) -- The "Chronic Pseudomonas Aeruginosa Pulmonary Infections - Pipeline Insight, 2024" has been added to ResearchAndMarkets.com's offering.This report provides...
Immuno-Oncology Strategic Industry Research Report 2023-2024 & 2030: Approval of Pembrolizumab (Keytruda) and Nivolumab (Opdivo), which Target PD-1 and PD-L1 Pathways have Set New Benchmarks
05 déc. 2024 10h16 HE
|
Research and Markets
Dublin, Dec. 05, 2024 (GLOBE NEWSWIRE) -- The "Immuno-Oncology - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Immuno-Oncology...